Comprehensive analysis of the role of interferon gamma-inducible protein 30 on immune infiltration and prognosis in clear cell renal cell carcinoma

Comprehensive analysis of the role of interferon gamma-inducible protein 30 on immune infiltration and prognosis in clear cell renal cell carcinoma

Although the immune factor interferon gamma-inducible protein 30 (IFI30) has been linked to the growth and immune infiltration of various malignancies, its function and mechanism in clear cell renal cell carcinoma (ccRCC) remains unclear. We used several databases to detect and validate IFI30 expre...

Full description

Bibliographic Details
Main Authors:	Xin Wen, Lei Lei, Fan Wang, Yuan Wang
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:	Biomolecules & Biomedicine
Subjects:	Interferon gamma-inducible protein 30 (IFI30); clear cell renal cell carcinoma (ccRCC); immune infiltration
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/9693

Similar Items

Identification of prognostic RNA editing profiles for clear cell renal carcinoma
by: Weihong Chen, et al.
Published: (2024-07-01)

Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
by: Wangli Mei, et al.
Published: (2022-08-01)

The elevated DERL3 expression indicates poor prognosis in renal clear-cell carcinoma
by: Weining Fan, et al.
Published: (2025-01-01)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
by: Yuxiong Jiang, et al.
Published: (2022-04-01)

Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma
by: Tong Cai, et al.
Published: (2023-01-01)

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration
by: Man Jia, et al.
Published: (2024-11-01)

Roles of cathepsin S expression levels on the prognosis and tumour microenvironment in clear cell renal cell carcinoma
by: Xiang Wang, et al.
Published: (2024-11-01)

Sirtuin 1, as a potential prognosis marker in renal clear cell carcinoma, regulates lipid metabolism and immune infiltration
by: Xuefei Wang, et al.
Published: (2024-02-01)

An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC
by: Guang Xia, et al.
Published: (2023-03-01)

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
by: Takafumi Narisawa, et al.
Published: (2023-02-01)

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma
by: Yuqing Zhang, et al.
Published: (2024-10-01)

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma
by: Shi-Yao Wei, et al.
Published: (2022-12-01)

Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma
by: Mancheng Gong, et al.
Published: (2023-10-01)

GLIPR2 emerges as a potential predictor of prognosis for renal clear cell carcinoma, exhibiting substantial relevance with cellular metastasis and CD8+ T cell infiltration
by: Hong Zeng, et al.
Published: (2024-01-01)

Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma
by: Songchen Han, et al.
Published: (2022-06-01)

Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
by: Dian Xia, et al.
Published: (2023-03-01)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
by: Jun Luo, et al.
Published: (2020-06-01)

<i>ENO2</i> as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
by: Jian Shi, et al.
Published: (2023-09-01)

Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma
by: Weiwei Yu, et al.
Published: (2022-10-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
by: Youlong Huili, et al.
Published: (2022-08-01)

High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
by: Pu Lei, et al.
Published: (2023-03-01)

FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
by: Jiachen Liu, et al.
Published: (2024-11-01)

Unveiling tumor-infiltrating immune cell-driven immune-mediated drug resistance in clear cell renal cell carcinoma: prognostic insights and therapeutic strategies
by: Jifeng Yang, et al.
Published: (2025-03-01)

Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis
by: Zezhong Yang, et al.
Published: (2024-02-01)

PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
by: Mamatha Garige, et al.
Published: (2022-05-01)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
by: Haitao Niu, et al.
Published: (2018-07-01)

Developing hypoxia and lactate metabolism-related molecular subtypes and prognostic signature for clear cell renal cell carcinoma through integrating machine learning
by: Jinhui Liu, et al.
Published: (2024-11-01)

Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma
by: Chuanjie Zhang, et al.
Published: (2022-05-01)

Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis
by: Youwei Yue, et al.
Published: (2023-10-01)

Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma
by: Justyna Durślewicz, et al.
Published: (2023-01-01)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
by: Laura K. Esser, et al.
Published: (2020-09-01)

Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma
by: Wenting Zhong, et al.
Published: (2022-08-01)

Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma
by: Ziwei Gui, et al.
Published: (2023-07-01)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
by: Guangjian Zhao, et al.
Published: (2022-12-01)

Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma
by: Gang Wang, et al.
Published: (2022-07-01)

RGS19 is a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma revealed through comprehensive bulk and single-cell sequencing analysis
by: Zhentao Lei, et al.
Published: (2025-03-01)

Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma
by: Fahui Liu, et al.
Published: (2022-06-01)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
by: Zuhu Yu, et al.
Published: (2023-03-01)

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
by: Zhi Liu, et al.
Published: (2023-01-01)